Skip to content
← Full study record

NCT00566540 · MORE INFO

Limitations, agreements, and source contact

Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer · Source last updated 2021-11-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
The study was stopped in the early stages and no data analysis was completed and results produced.
point Of Contact
email
enver.ozer@osumc.edu
organization
The Ohio State University Comprehensive Cancer Center
phone
614-293-8074
title
Enzer Ozer, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
The study was stopped in the early stages and no data analysis was completed and results produced.
point Of Contact
email
enver.ozer@osumc.edu
organization
The Ohio State University Comprehensive Cancer Center
phone
614-293-8074
title
Enzer Ozer, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice